Walgreens designates 50 pharmacies as cancer care centers

Walgreens recently designated over 50 of its nationwide pharmacy locations as cancer specialty centers outfitted with highly trained staff in breast, prostate, colorectal, lung and blood cancer directives with specialized curricula.
Matthew Farber, Walgreens senior director for oncology disease state management, noted that the company is always aiming for better methods to support cancer patients through the specialty pharmacies as well as serving as liaisons to their customers’ other health care providers.
“With the continued advances in new oral therapies for cancer care, our pharmacists … are playing an integral role in working with patients’ physicians, nurses, social workers and financial counselors,” Farber said.
Additionally, Walgreens has partnered with the Leukemia & Lymphoma Society to develop educational protocols.
“We are passionate about understanding, meeting and exceeding the needs of blood cancer patients,” Leukemia & Lymphoma Society President and CEO Louis DeGennaro said. “Our programs, priorities and policies are driven by what is right for patients.”
DeGennaro added that its work with Walgreens is positively impacting the health care of over 1.2 million people nationwide living with or in remission from a blood cancer.